Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Defense Against Bacterial Pathogens
Staphylococcal Skin Infections
Healthcare Associated Infections II: Preventive Measures
Healthcare Agencies II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 23, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Virginia Jackson1, David B Nash
1Virginia Jackson is a second-year medical student at Jefferson Medical College of Thomas Jefferson University, Philadelphia. She can be reached at « virginia.jackson@jefferson.edu ».David B. Nash, MD, MBA, is the Dr. Raymond C. and Doris N. Grandon Professor and chairman of the Department of Health Policy at Jefferson Medical College. Nash also chairs Biotechnology Healthcare's editorial advisory board. He can be reached at « david.nash@jefferson.edu »
Medicare is reducing payments for preventable hospital errors, increasing demand for infection control solutions. Innovations combining information technology and biotechnology offer improved patient care and resource efficiency.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: